Enhanced Immunogenicity and Protective Efficacy of a <i>Campylobacter jejuni</i> Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21.
Ramakrishnan, Amritha; Schumack, Nina M; Gariepy, Christina L; Eggleston, Heather; Nunez, Gladys; Espinoza, Nereyda; Nieto, Monica; Castillo, Rosa; Rojas, Jesus; McCoy, Andrea J; Beck, Zoltan; Matyas, Gary R; Alving, Carl R; Guerry, Patricia; Poly, Frédéric; Laird, Renee M.
; 4(3)2019 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-31043512
STAT4 is required for the generation of Th1 and Th2, but not Th17 immune responses during monophosphoryl lipid A adjuvant activity.
The Lymphatic Immune Response Induced by the Adjuvant AS01: A Comparison of Intramuscular and Subcutaneous Immunization Routes.
Inflammasome activation by Campylobacter jejuni.
Control strategies against Campylobacter at the poultry production level: biosecurity measures, feed additives and vaccination.
Evaluation of a protective effect of in ovo delivered Campylobacter jejuni OMVs.
Safety and skin delayed-type hypersensitivity response in vervet monkeys immunized with Leishmania donovani sonicate antigen delivered with adjuvants
The importance of adjuvant formulation in the development of a tuberculosis vaccine.
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1.
Immunopathology and Th1/Th2 immune response of Campylobacter jejuni-induced paralysis resembling Guillain-Barré syndrome in chicken.
The role of endotoxin in infection: Helicobacter pylori and Campylobacter jejuni.